George Naumov is a biotech executive and operator with deep scientific roots and more than two decades of experience translating discovery into clinical programs, currently serving as COO and Chief Business Officer at RS Oncology. He has led clinical science and development efforts across oncology programs—from PARP inhibitors at TESARO to first-in-class nuclear transport targets at Karyopharm—and co-founded an early-stage therapeutics company. Trained as a cancer biophysicist with a Harvard postdoc and a PhD in Medical Biophysics, he blends hands-on lab pedigree with deal-making and cross-disciplinary collaboration between academia and industry. Based in Brookline, MA, he focuses on mitochondrial-targeted, biomarker-driven therapeutics and operationalizing translational partnerships. Unusually for a senior biotech leader, he applies data and coding skills (Python/R) to accounting and analytics workflows and is exploring Rust systems programming for fun, signaling a practical curiosity about tooling and reproducible science.
8 years of coding experience
6 years of employment as a software developer
Ph.D. Medical Biophysics (Oncology), Ph.D. Medical Biophysics (Oncology) at Western University
Post-doctoral fellow Cancer Research, Post-doctoral fellow Cancer Research at Harvard Medical School
B.Sci.(Hon) Biochemistry, B.Sci.(Hon) Biochemistry at Queen's University
Contributions:3 releases, 25 pushes, 1 branch in 6 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
George Naumov - Chief Operations Officer & Chief Business Officer